An average methylation of the whole RASSF1A promoter region higher than 20% results in a reduced RASSF1A mRNA expression in various cancer cell lines, suggesting that it represents a critical threshold for efficient gene silencing [109]. The gene discussed is RASSF1; the disease is cancer.